Friday, December 15, 2006
Cutting edge policies for cutting edge science
(Proposed standards and regulations for State-funded for-profit stem cell research.)
A Proposed State Policy for Wisconsin for State-funded For-Profit Stem Cell Research
Terms and conditions for State funded grants to for-profit entities engaged in stem sell research.
1. The State of Wisconsin will realize a return on state funded grants and stipends, as well as non-financial state benefits and dispensations granted to for-profit stem cell entities whenever a commercial project generates a pre-determined amount of revenue, i.e., $500,000.
2. The state’s financial participation will rise with a project’s financial success and will include royalty payments for any private initiative that achieves an inordinate financial status of a pre-determined (and significantly higher than above) amount of revenue, i.e. $500 million dollars.
3. In addition to financial returns, the State of Wisconsin expects to benefit from its investment by requiring for-profit grant recipients to make stem cell therapies available to uninsured Wisconsin residents consistent with industry standards; to provide discounted prices to publicly funded health care plans; and to grant Wisconsin residents preference if therapies are in short supply.
(This model for terms and conditions for grants to for-profit stem cell entities is taken from the California Institute for Regenerative Medicine’s Independent Citizens Oversight Committee (ICOC), December 7, 2006.)
(http://www.cirm.ca.gov/pressreleases/2006/12/12-07-06.asp)
A Proposed State Policy for Wisconsin for State-funded For-Profit Stem Cell Research
Terms and conditions for State funded grants to for-profit entities engaged in stem sell research.
1. The State of Wisconsin will realize a return on state funded grants and stipends, as well as non-financial state benefits and dispensations granted to for-profit stem cell entities whenever a commercial project generates a pre-determined amount of revenue, i.e., $500,000.
2. The state’s financial participation will rise with a project’s financial success and will include royalty payments for any private initiative that achieves an inordinate financial status of a pre-determined (and significantly higher than above) amount of revenue, i.e. $500 million dollars.
3. In addition to financial returns, the State of Wisconsin expects to benefit from its investment by requiring for-profit grant recipients to make stem cell therapies available to uninsured Wisconsin residents consistent with industry standards; to provide discounted prices to publicly funded health care plans; and to grant Wisconsin residents preference if therapies are in short supply.
(This model for terms and conditions for grants to for-profit stem cell entities is taken from the California Institute for Regenerative Medicine’s Independent Citizens Oversight Committee (ICOC), December 7, 2006.)
(http://www.cirm.ca.gov/pressreleases/2006/12/12-07-06.asp)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment